Skip to the main content.

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

White Paper: Laboratory Developed Tests: Overview of the Regulatory Framework in Europe vs. USA

White Paper: Laboratory Developed Tests: Overview of the Regulatory Framework in Europe vs. USA

[dpvfw_pdf_viewer_embed pdfviewer=”13199″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][/dpvfw_pdf_viewer_embed]

CONTINUE LEARNING…

Laboratory Developed Tests: Overview of the Regulatory Framework in Europe vs. USA

Laboratory Developed Tests: Overview of the Regulatory Framework in Europe vs. USA

In this white paper, our regulatory team presents the frameworks governing Laboratory Developed Tests in Europe and the USA, and discuss...

Read More
A Virtual Tutorial on Regulatory Pathways for Diagnostic Tests in the US and Europe

A Virtual Tutorial on Regulatory Pathways for Diagnostic Tests in the US and Europe

In this webinar, experts from Goldbug Strategies and Veranex discuss available regulatory pathways for bringing a new generation of innovative...

Read More

1 min read

Medicare Clarifies Confusion Over Tests Covered by the NGS NCD

The Medicare NGS NCD grants national coverage for somatic testing in patients with advanced cancer if the test has FDA-approval or -clearance as a...

Read More